CORD-19:8ba20a12c92103d82364b8abca49cfcd91d91c13 / 2835-3154 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T21","span":{"begin":0,"end":319},"obj":"Sentence"},{"id":"TextSentencer_T21","span":{"begin":0,"end":319},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Wandall et al. [13] developed an O-glycopeptide microarray to monitor human autoantibody responses to tumor antigens that they successfully used to detect cancer-associated IgG autoantibodies against different aberrant O-glycopeptide epitopes derived from MUC1 in sera from breast, ovarian and prostate cancer patients."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T26","span":{"begin":102,"end":107},"obj":"Disease"},{"id":"T27","span":{"begin":155,"end":161},"obj":"Disease"},{"id":"T28","span":{"begin":294,"end":309},"obj":"Disease"},{"id":"T29","span":{"begin":303,"end":309},"obj":"Disease"},{"id":"T72202","span":{"begin":102,"end":107},"obj":"Disease"},{"id":"T35667","span":{"begin":155,"end":161},"obj":"Disease"},{"id":"T24130","span":{"begin":294,"end":309},"obj":"Disease"},{"id":"T95495","span":{"begin":303,"end":309},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A40870","pred":"mondo_id","subj":"T72202","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A46643","pred":"mondo_id","subj":"T35667","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A41220","pred":"mondo_id","subj":"T24130","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A54101","pred":"mondo_id","subj":"T95495","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Wandall et al. [13] developed an O-glycopeptide microarray to monitor human autoantibody responses to tumor antigens that they successfully used to detect cancer-associated IgG autoantibodies against different aberrant O-glycopeptide epitopes derived from MUC1 in sera from breast, ovarian and prostate cancer patients."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T5","span":{"begin":274,"end":280},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Wandall et al. [13] developed an O-glycopeptide microarray to monitor human autoantibody responses to tumor antigens that they successfully used to detect cancer-associated IgG autoantibodies against different aberrant O-glycopeptide epitopes derived from MUC1 in sera from breast, ovarian and prostate cancer patients."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T23","span":{"begin":102,"end":107},"obj":"Phenotype"},{"id":"T24","span":{"begin":155,"end":161},"obj":"Phenotype"},{"id":"T25","span":{"begin":294,"end":309},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0012125"}],"text":"Wandall et al. [13] developed an O-glycopeptide microarray to monitor human autoantibody responses to tumor antigens that they successfully used to detect cancer-associated IgG autoantibodies against different aberrant O-glycopeptide epitopes derived from MUC1 in sera from breast, ovarian and prostate cancer patients."}